Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group | Zendy

ChyongHuey Lai | Zendy; Elizabeth Vallikad | Zendy; Hao Lin | Zendy; LanYan Yang | Zendy; ShihMing Jung | Zendy; HsuehErh Liu | Zendy; YuChe Ou | Zendy; HungHsueh Chou | Zendy; Cheng-Tao Lin | Zendy; HueiJean Huang | Zendy; KuanGen Huang | Zendy; JianTai Qiu | Zendy; YaoChing Hung | Zendy; Tzu-I Wu | Zendy; WeiYang Chang | Zendy; Kien Thiam Tan | Zendy; ChiaoYun Lin | Zendy; Angel Chao | Zendy; CheeJen Chang | Zendy

Open Access

Maintenance of pegylated liposomal doxorubicin/carboplatin in patients with advanced ovarian cancer: randomized study of an Asian Gynecologic Oncology Group

Author(s) -

ChyongHuey Lai,

Elizabeth Vallikad,

Hao Lin,

LanYan Yang,

ShihMing Jung,

HsuehErh Liu,

YuChe Ou,

HungHsueh Chou,

Cheng-Tao Lin,

HueiJean Huang,

KuanGen Huang,

JianTai Qiu,

YaoChing Hung,

Tzu-I Wu,

WeiYang Chang,

Kien Thiam Tan,

ChiaoYun Lin,

Angel Chao,

CheeJen Chang

Publication year - 2019

Publication title -

journal of gynecologic oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.358

H-Index - 37

eISSN - 2005-0399

pISSN - 2005-0380

DOI - 10.3802/jgo.2020.31.e5

Subject(s) - medicine , carboplatin , gynecologic oncology , oncology , ovarian cancer , randomized controlled trial , doxorubicin , chemotherapy , gynecology , cancer , cisplatin

Despite limitations in small sample size, it suggests that maintenance carboplatin-PLD chemotherapy could improve PFS in advanced ovarian cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research